How many studies have been conducted on Oncostatin M?

BiohacksAI has indexed 300 PubMed studies on Oncostatin M. 22% of studies involve human subjects.

What are the main research areas for Oncostatin M?

The primary research domains for Oncostatin M are 🔬 Inflammation, 🔬 Oncology, 🛡️ Immunity. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Oncostatin M

A cytokine with both pro- and anti-inflammatory actions that depend upon the cellular microenvironment. Oncostatin M is a 28 kDa monomeric glycoprotein that is similar in structure to LEUKEMIA INHIBITORY FACTOR. Its name derives from the the observation that it inhibited the growth of tumor cells and augmented the growth of normal fibroblasts.

300+ PubMed studies analyzed · Evidence Score: 46.7

Research Domains

Oncostatin M has been studied across 21 research domains including 🔬 Inflammation, 🔬 Oncology, 🛡️ Immunity, 🦴 Bone & Joint, ✨ Skin & Hair. The primary research focus is 🔬 Inflammation with 35% of studies addressing this area.

Loading evidence profile...

This evidence profile for Oncostatin M is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.